Immunome, Inc. (IMNM)
21.21
+0.03
(+0.14%)
USD |
NASDAQ |
Dec 31, 09:53
Immunome Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 31.72% |
| Amphastar Pharmaceuticals, Inc. | 9.04% |
| Relay Therapeutics, Inc. | -- |
| Prelude Therapeutics, Inc. | -303.5% |
| Context Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -90.08% |
| Return on Assets | -77.58% |
| Return on Invested Capital | -88.61% |
| Return on Net Operating Assets | -1.64K% |